Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb (BMY) Takeover Less Likely Following Pfizer (PFE) Call - BMO

January 31, 2017 3:04 PM
BMO Capital analyst Alex Arfaei said a takeover of Bristol-Myers Squibb Co. (NYSE: BMY) appears less likely following Pfizer's (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Rumors

Next Articles